
Global leader in dermatology, Galderma Laboratories LP delivers innovative skincare, aesthetic, and therapeutic solutions, serving consumers and healthcare professionals worldwide.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Galderma has recently focused on expanding its portfolio with new dermatological therapies, digital health initiatives, and global market growth, reflecting industry trends in personalized skincare and aesthetics.
Launch of new prescription treatments for atopic dermatitis and prurigo nodularis
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Galderma Laboratories LP focuses exclusively on dermatology, providing advanced solutions across injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio includes well-known brands such as Cetaphil, Differin, Restylane, and Azzalure, addressing conditions like acne, rosacea, eczema, psoriasis, and skin aging. The company collaborates closely with healthcare professionals to deliver superior outcomes and meet individual patient needs. Galderma’s integrated strategy and global reach position it as a category leader in the dermatology sector.